National Biodefense Science Board; Call for Nominees, 40480-40481 [2013-16178]
Download as PDF
<![CDATA[
40480
Federal Register / Vol. 78, No. 129 / Friday, July 5, 2013 / Notices
Michael Chertoff, determined, pursuant
to section 564(b)(1)(A) of the FD&C Act,
that there is a significant potential for a
domestic emergency involving a
heightened risk of attack with a
specified biological, chemical,
radiological, or nuclear agent or
agents—in this case, Bacillus
anthracis—although there is no current
domestic emergency involving anthrax,
no current heightened risk of an anthrax
attack, and no credible information
indicating an imminent threat of an
attack involving Bacillus anthracis. On
October 1, 2008, on the basis of that
determination, and pursuant to section
564(b) of the FD&C Act, former HHS
Secretary, Michael O. Leavitt, declared
an emergency justifying the emergency
use of doxycycline hyclate tablets
accompanied by emergency use
information subject to the terms of any
authorization issued under section
564(a) of the FD&C Act.2 On October 1,
2009 and October 1, 2010, I renewed the
former Secretary’s declaration,3 and on
July 20, 2011, I renewed and amended
the declaration to declare that the
emergency justifies emergency use of all
oral formulations of doxycycline
accompanied by emergency use
information subject to the terms of any
authorization issued under section
564(a) of the FD&C Act.4 On June 28,
2012, I renewed my July 20, 2011
declaration.5
II. Declaration of the Secretary of
Health and Human Services
tkelley on DSK3SPTVN1PROD with NOTICES
On the basis of the September 23,
2008 determination by the Secretary of
Homeland Security and pursuant to
section 564(b) of the FD&C Act, I hereby
declare that circumstances exist
justifying the authorization of
emergency use of all oral formulations
of doxycycline accompanied by
emergency use information subject to
the terms of any authorization issued
under section 564(a) of the FD&C Act.6
2 Pursuant to section 564(b)(4) of the FD&C Act,
notice of the determination by the Secretary of
Homeland Security and the declaration by the HHS
Secretary was provided at 73 FR 58242 (October 6,
2008).
3 Pursuant to section 564(b)(4) of the FD&C Act,
notices of the renewals of the declaration of the
HHS Secretary were provided at 74 FR 51,279 (Oct.
6, 2009) and 75 FR 61,489 (Oct. 5, 2010).
4 Pursuant to section 564(b)(4) of the FD&C Act,
notice of the renewal and amendment of the
declaration of the HHS Secretary was provided at
76 FR 44,926 (July 27, 2011).
5 Pursuant to section 564(b)(4) of the FD&C Act,
notice of the renewal of the declaration of the HHS
Secretary was provided at 77 FR 39,708 (July 5,
2012).
6 Section 564(b)(1) of the FD&C Act was amended
by section 302 of the Pandemic and All-Hazards
Preparedness Reauthorization Act, Public Law 113–
5, to provide that the HHS Secretary may ‘‘make a
VerDate Mar<15>2010
17:06 Jul 03, 2013
Jkt 229001
I am issuing this notice in accordance
with section 564(b)(4) of the FD&C Act.
Dated: June 27, 2013.
Kathleen Sebelius,
Secretary.
[FR Doc. 2013–16177 Filed 7–3–13; 8:45 am]
BILLING CODE 4150–37–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Biodefense Science Board;
Call for Nominees
Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
The deadline for all
application submissions to the National
Biodefense Science Board (NBSB) is
extended from July 7, 2013, to August
4, 2013 at 11:59 p.m. The Office of the
Secretary is accepting application
submissions from qualified individuals
who wish to be considered for
membership on the NBSB; six members
have membership expiration dates of
December 31, 2013, therefore, six new
voting members will be selected for the
Board. Nominees are being accepted in
the following categories: Industry,
Academia, Healthcare Consumer
Organizations, and Organizations
Representing Other Appropriate
Stakeholders. Please visit the NBSB
Web site at www.phe.gov/nbsb for all
application submission information and
instructions. All members of the public
are encouraged to apply.
FOR FURTHER INFORMATION CONTACT:
CAPT Charlotte Spires, DVM, MPH,
DACVPM, Executive Director and
Designated Federal Official, National
Biodefense Science Board, Office of the
Assistant Secretary for Preparedness
and Response, U.S. Department of
Health and Human Services, Thomas P.
O’Neill Federal Building, Room number
14F18, 200 C St. SW., Washington, DC
20024; Office: 202–260–0627, Email
address: charlotte.spires@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to section 319M of the Public Health
Service Act (42 U.S.C. 247d–7f) and
section 222 of the Public Health Service
Act (42 U.S.C. 217a), the Department of
SUMMARY:
declaration that the circumstances exist justifying
the authorization’’ for a product under section 564
of the FD&C Act on the basis of one of four
determinations specified under subsection 564(b)(1)
of the FD&C Act, including a determination by the
Secretary of Homeland Security that there is a
domestic emergency, or a significant potential for
a domestic emergency, involving a heightened risk
of attack with a chemical, biological, radiological,
or nuclear agent or agents.
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Health and Human Services established
the National Biodefense Science Board.
The Board shall provide expert advice
and guidance to the Secretary on
scientific, technical, and other matters
of special interest to the Department of
Health and Human Services regarding
current and future chemical, biological,
nuclear, and radiological agents,
whether naturally occurring, accidental,
or deliberate. The Board may also
provide advice and guidance to the
Secretary and/or the Assistant Secretary
for Preparedness and Response (ASPR)
on other matters related to public health
emergency preparedness and response.
Description of Duties: The Board shall
advise the Secretary and/or ASPR on
current and future trends, challenges,
and opportunities presented by
advances in biological and life sciences,
biotechnology, and genetic engineering
with respect to threats posed by
naturally occurring infectious diseases
and chemical, biological, radiological,
and nuclear agents. At the request of the
Secretary and/or ASPR, the Board shall
review and consider any information
and findings received from the working
groups established under 42 U.S.C.
247d–7f(b). At the request of the
Secretary and/or ASPR, the Board shall
provide recommendations and findings
for expanded, intensified, and
coordinated biodefense research and
development activities. Additional
advisory duties concerning public
health emergency preparedness and
response may be assigned at the
discretion of the Secretary and/or ASPR.
Structure: The Board shall consist of
13 voting members, including the
Chairperson; additionally, there may be
non-voting ex officio members. Pursuant
to 42 U.S.C. 247d–7f(a), members and
the chairperson shall be appointed by
the Secretary from among the Nation’s
preeminent scientific, public health and
medical experts, as follows: (a) Such
federal officials as the Secretary
determines are necessary to support the
functions of the Board, (b) four
individuals from the pharmaceutical,
biotechnology and device industries, (c)
four academicians, and (d) five other
members as determined appropriate by
the Secretary and/or ASPR, one of
whom must be a practicing health care
professional, one of whom must be from
an organization representing health care
consumers, one of whom must have
pediatric subject matter expertise, and
one of whom shall be a State, tribal,
territorial, or local public health official.
Additional members for category (d),
above, will be selected from among
emergency medical responders and
organizations representing other
appropriate stakeholders. A member of
E:\FR\FM\05JYN1.SGM
05JYN1
40481
Federal Register / Vol. 78, No. 129 / Friday, July 5, 2013 / Notices
the Board described in (b), (c), and (d)
in the above paragraph shall serve for a
term of 3 years, except that the Secretary
may adjust the terms of the initial Board
appointees in order to provide for a
staggered term of appointment of all
members. Members who are not fulltime
or permanent part-time federal
employees shall be appointed by the
Secretary as Special Government
Employees.
Dated: June 28, 2013.
Nicole Lurie,
Assistant Secretary for Preparedness and
Response, U.S. Department of Health and
Human Services.
is the most comprehensive listing of
HIV/AIDS, viral hepatitis, STD, and TB
resources and services available
throughout the country. The American
public can also access the NPIN
Resources and Services database
through the NPIN Web site. More than
56 million hits by the public to the Web
site are recorded annually.
To accomplish CDC’s goal of
continuing efforts to maintain an up-todate, comprehensive database, NPIN
plans each year to add up to 500 newly
identified organizations and to verify
those organizations currently described
in the NPIN Resources and Services
Database each year. Organizations with
access to the Internet will be given the
option to complete and submit an
electronic version of the questionnaire
by visiting the NPIN Web site. The
breakdown of the total annualized
burden hours by survey instrument is as
follows:
Initial Questionnaire Telephone
Script—600 respondents with one
response each (120 Registered Nurses—
20 minutes; 20 Social and Community
Service Managers—10 minutes; 20
Health Educators—13 minutes; and 120
Social and Human Service Assistants—
15 minutes), for a total of 152 burden
hours
Telephone Verification—7,200
respondents with one response each
(1,200 Registered Nurses, 600 Social and
Community Service Managers, and 600
Health Educators—10 minutes; and
4,800 Social and Human Services
Assistants—9 minutes) for a total of
1,120 burden hours
Email Verification—3,600
respondents with one response each
(600 Registered Nurses, 300 Health
Educators, and 2,400 Social and Human
Services Assistants—10 minutes); and
300 Social and Community Service
Managers—12 minutes) for a total of 610
burden hours. This request is for 3years. There are no costs to respondents
other than their time.
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Resources and Services Database of
the CDC National Prevention
Information Network (NPIN) (OMB No.
0920–0255 exp. 1/31/2014)—
Extension—National Center for HIV/
AIDS, Viral Hepatitis, Sexually
Transmitted Diseases, and Tuberculosis
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
[FR Doc. 2013–16178 Filed 7–3–13; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–13–0255]
Agency Information Collection
Activities; Proposals, Submissions,
and Approvals
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Leroy Richardson, at 1600
Clifton Road, MS D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
Background and Brief Description
NCHHSTP has the primary
responsibility within the CDC and the
U.S. Public Health Service for the
prevention and control of HIV infection,
viral hepatitis, sexually transmitted
diseases (STDs), and tuberculosis (TB),
as well as for community-based HIV
prevention activities, syphilis, and TB
elimination programs. NPIN serves as
the U.S. reference, referral, and
distribution service for information on
HIV/AIDS, viral hepatitis, STDs, and
TB, supporting NCHHSTP’s mission to
link Americans to prevention,
education, and care services. NPIN is a
critical member of the network of
government agencies, community
organizations, businesses, health
professionals, educators, and human
services providers that educate the
American public about the grave threat
to public health posed by HIV/AIDS,
viral hepatitis, STDs, and TB, and
provides services for persons infected
with human immunodeficiency virus
(HIV).
The NPIN Resources and Services
Database contains entries on
approximately 9,000 organizations and
ESTIMATED ANNUALIZED BURDEN HOURS
Form
Number of
respondents
Respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
tkelley on DSK3SPTVN1PROD with NOTICES
Initial Questionnaire Telephone Script.
Registered nurses ...........................................
100
1
20/60
33
Telephone Verification .......
Social and community service managers .......
Health educators .............................................
Social and human service assistants .............
Registered nurses, Social and community
service managers, and Health educators.
Social and human service assistants .............
Registered nurses, Health educators, and Social and human service assistants.
50
50
400
2,400
1
1
1
1
10/60
13/60
15/60
10/60
8
11
100
400
4,800
3,300
1
1
9/60
10/60
720
550
Email Verification ...............
VerDate Mar<15>2010
18:09 Jul 03, 2013
Jkt 229001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
E:\FR\FM\05JYN1.SGM
05JYN1
]]>Agencies
[Federal Register Volume 78, Number 129 (Friday, July 5, 2013)]
[Notices]
[Pages 40480-40481]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-16178]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Biodefense Science Board; Call for Nominees
AGENCY: Office of the Secretary, Department of Health and Human
Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The deadline for all application submissions to the National
Biodefense Science Board (NBSB) is extended from July 7, 2013, to
August 4, 2013 at 11:59 p.m. The Office of the Secretary is accepting
application submissions from qualified individuals who wish to be
considered for membership on the NBSB; six members have membership
expiration dates of December 31, 2013, therefore, six new voting
members will be selected for the Board. Nominees are being accepted in
the following categories: Industry, Academia, Healthcare Consumer
Organizations, and Organizations Representing Other Appropriate
Stakeholders. Please visit the NBSB Web site at www.phe.gov/nbsb for
all application submission information and instructions. All members of
the public are encouraged to apply.
FOR FURTHER INFORMATION CONTACT: CAPT Charlotte Spires, DVM, MPH,
DACVPM, Executive Director and Designated Federal Official, National
Biodefense Science Board, Office of the Assistant Secretary for
Preparedness and Response, U.S. Department of Health and Human
Services, Thomas P. O'Neill Federal Building, Room number 14F18, 200 C
St. SW., Washington, DC 20024; Office: 202-260-0627, Email address:
charlotte.spires@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant to section 319M of the Public
Health Service Act (42 U.S.C. 247d-7f) and section 222 of the Public
Health Service Act (42 U.S.C. 217a), the Department of Health and Human
Services established the National Biodefense Science Board. The Board
shall provide expert advice and guidance to the Secretary on
scientific, technical, and other matters of special interest to the
Department of Health and Human Services regarding current and future
chemical, biological, nuclear, and radiological agents, whether
naturally occurring, accidental, or deliberate. The Board may also
provide advice and guidance to the Secretary and/or the Assistant
Secretary for Preparedness and Response (ASPR) on other matters related
to public health emergency preparedness and response.
Description of Duties: The Board shall advise the Secretary and/or
ASPR on current and future trends, challenges, and opportunities
presented by advances in biological and life sciences, biotechnology,
and genetic engineering with respect to threats posed by naturally
occurring infectious diseases and chemical, biological, radiological,
and nuclear agents. At the request of the Secretary and/or ASPR, the
Board shall review and consider any information and findings received
from the working groups established under 42 U.S.C. 247d-7f(b). At the
request of the Secretary and/or ASPR, the Board shall provide
recommendations and findings for expanded, intensified, and coordinated
biodefense research and development activities. Additional advisory
duties concerning public health emergency preparedness and response may
be assigned at the discretion of the Secretary and/or ASPR.
Structure: The Board shall consist of 13 voting members, including
the Chairperson; additionally, there may be non-voting ex officio
members. Pursuant to 42 U.S.C. 247d-7f(a), members and the chairperson
shall be appointed by the Secretary from among the Nation's preeminent
scientific, public health and medical experts, as follows: (a) Such
federal officials as the Secretary determines are necessary to support
the functions of the Board, (b) four individuals from the
pharmaceutical, biotechnology and device industries, (c) four
academicians, and (d) five other members as determined appropriate by
the Secretary and/or ASPR, one of whom must be a practicing health care
professional, one of whom must be from an organization representing
health care consumers, one of whom must have pediatric subject matter
expertise, and one of whom shall be a State, tribal, territorial, or
local public health official. Additional members for category (d),
above, will be selected from among emergency medical responders and
organizations representing other appropriate stakeholders. A member of
[[Page 40481]]
the Board described in (b), (c), and (d) in the above paragraph shall
serve for a term of 3 years, except that the Secretary may adjust the
terms of the initial Board appointees in order to provide for a
staggered term of appointment of all members. Members who are not
fulltime or permanent part-time federal employees shall be appointed by
the Secretary as Special Government Employees.
Dated: June 28, 2013.
Nicole Lurie,
Assistant Secretary for Preparedness and Response, U.S. Department of
Health and Human Services.
[FR Doc. 2013-16178 Filed 7-3-13; 8:45 am]
BILLING CODE P
